Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo.
Prostate. 2019 Feb;79(2):168-182. doi: 10.1002/pros.23722. Epub 2018 Sep 27.
Prostate. 2019.
PMID: 30264470